UMVA has learned that a major Canadian online health-care platform is shaking up the market by offering customers access to lower-cost semaglutide, a game-changing drug used to treat Type 2 diabetes and weight loss.

UMVA has learned that a major Canadian online health-care platform is shaking up the market by offering customers access to lower-cost semaglutide, a game-changing drug used to treat Type 2 diabetes and weight loss.
